Consensus-based statements for the management of mitochondrial stroke-like episodes
: Ng Y.S., Bindoff L.A., Gorman G.S., Horvath R., Klopstock T., Mancuso M., Martikainen M.H., Mcfarland R., Nesbitt V., Pitceathly R.D.S., Schaefer A.M., Turnbull D.M.
Publisher: F1000 Research Ltd
: 2019
: Wellcome Open Research
: Wellcome Open Research
: 201
: 4
: 2398-502X
: 2398-502X
DOI: https://doi.org/10.12688/wellcomeopenres.15599.1
: https://research.utu.fi/converis/portal/detail/Publication/52239584
Background: Focal-onset seizures and encephalopathy are prominent features of a stroke-like episode, which is a severe neurological manifestation associated with subtypes of mitochondrial disease. Despite more than 30 years of research, the acute treatment of stroke-like episodes remains controversial.
Methods: We used the modified Delphi process to harness the clinical expertise of a group of mitochondrial disease specialists from five European countries to produce consensus guidance for the acute management of stroke-like episodes and commonly associated complications.
Results: Consensus on a new definition of mitochondrial stroke-like episodes was achieved and enabled the group to develop diagnostic criteria based on clinical features, neuroimaging and/or electroencephalogram findings. Guidelines for the management of strokelike episodes were agreed with aggressive seizure management strongly recommended at the outset of stroke-like episodes.
Conclusions: Our consensus statement defines stroke-like episodes in terms of an epileptic encephalopathy and we have used this to revise both diagnostic criteria and guidelines for management. A prospective, multi-centre, randomised controlled trial is required for evaluating the efficacy of any compound on modifying the trajectory of stroke-like episodes.